Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Reata Pharma
(NQ:
RETA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 25, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Reata Pharma
< Previous
1
2
3
4
5
6
7
8
9
Next >
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.
Via
Benzinga
An Oversold Gold Miner With Strong Fundamentals--Its Relative Strength Index Is Below 20, And Its Piotroski F-Score Is 8
October 05, 2023
Paying Attention To Gold Miners On Zero Hedge on Monday, contributing editor “Quoth The Raven” suggested “paying urgent attention to gold miners”:
Via
Benzinga
Does Biogen's Latest $1.5 Billion-Dollar Move Make It a Buy?
September 09, 2023
Buying a biotech is a good move, but it might not be enough to entice investors.
Via
The Motley Fool
7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth
September 07, 2023
Finding the best pharma stocks to buy takes a little effort, but it will pay of with these seven long-term winners.
Via
InvestorPlace
Analyst Ratings for Reata Pharmaceuticals
August 15, 2023
Via
Benzinga
Health Care Company Biogen Announces Acquisition of Reata Pharmaceuticals
July 28, 2023
Via
Benzinga
Expert Ratings for Reata Pharmaceuticals
July 24, 2023
Via
Benzinga
The 7 Most Promising Momentum Stocks to Own Now
August 31, 2023
These momentum stock picks are on a run, but it isn't too late to ride the rollercoaster amid broad market volatility.
Via
InvestorPlace
The 3 Most Promising Pharma Stocks to Own Now
August 30, 2023
A pillar to economic growth in a defensive area, these promising pharma stocks are set to rise and give investors one bullish ride.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
August 14, 2023
Via
Benzinga
With an Acquisition on the Way, Is Biogen Stock a Buy?
August 09, 2023
Can the biotech finally get back in the good graces of investors?
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
August 08, 2023
Via
Benzinga
Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points
August 01, 2023
Investors looking to give their portfolio a boost should consider one of these leading biotech names, which are undervalued right now.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023
August 01, 2023
Via
Benzinga
Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know.
August 01, 2023
Biogen also recently announced a plan to cut costs and focus investment on high-growth areas.
Via
The Motley Fool
Could This Stock Be the Next Biotech Buyout?
July 31, 2023
A buyout deal recently pushed Reata Pharmaceuticals stock 53% higher in a single trading session, leading investors to wonder who's next.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
July 31, 2023
Via
Benzinga
Crude Oil Edges Higher; Colgate-Palmolive Posts Upbeat Earnings
July 28, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 250 points on Friday. The Dow traded up 0.42% to 35,432.07 while the NASDAQ rose 1.79% to 14,301.74. The...
Via
Benzinga
Stock Market Rallies Amid Huge Earnings, Fed Rate Hike, Inflation Data: Weekly Review
July 28, 2023
Despite Thursday's downside reversal, the major indexes had a solid advance.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Friday's Intraday Session
July 28, 2023
Via
Benzinga
Why Avantor Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 28, 2023
Gainers Unique Fabricating, Inc. (NYSE: UFAB) shares jumped 113% to $0.4605 after gaining 12% on Thursday.
Via
Benzinga
Dow Surges 250 Points; Exxon Mobil Earnings Miss Expectations
July 28, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 250 points on Friday. The Dow traded up 0.72% to 35,535.23 while the NASDAQ rose 1.89% to 14,316.53. The S&P 500,...
Via
Benzinga
Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated
July 28, 2023
Earlier today, Biogen Inc (NASDAQ: BIIB) agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA) for $172.50 per share in cash, reflecting an enterprise value of
Via
Benzinga
Skechers, Chart Industries, Roku, Beazer Homes And Other Big Stocks Moving Higher On Friday
July 28, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session. Reata Pharmaceuticals, Inc. (NASDAQ: RETA) rose...
Via
Benzinga
Why Is QuantumScape (QS) Stock Up 10% Today?
July 28, 2023
QuantumScape (QS) stock is continuing to rally on Friday following an update from its latest earnings report and EV battery plans.
Via
InvestorPlace
Why Is Reata Pharmaceuticals (RETA) Stock Up 53% Today?
July 28, 2023
Reata Pharmaceuticals (RETA) stock is soaring higher on Friday as investors react to an acquisition deal with Biogen (BIIB).
Via
InvestorPlace
Nasdaq Jumps 200 Points; Procter & Gamble Posts Upbeat Earnings
July 28, 2023
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining more than 200 points on Friday. Following the market opening Friday, the Dow traded up 0.39% to 35,419.43 while the NASDAQ rose...
Via
Benzinga
Biogen Announces $7.3 Billion Acquisition Of Reata Pharmaceuticals
July 28, 2023
Reata stock surged more than 50% on the news.
Via
Investor's Business Daily
Biogen Bolsters Rare Disease Portfolio, Agrees To Buy Reata Pharmaceuticals With Enterprise Value Of $7.3B
July 28, 2023
Biogen Inc (NASDAQ: BIIB) has agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA) for $172.50 per share in cash, reflecting an enterprise value of
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 28, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.